Cambrex or Thermo Fisher for CDMO business acquisition—each has M/A activity in background. I am mindful of Xencor.
Meantime, we should be looking for evidence of milestones/royalties that could stem from success in clinical trials in which MRK is collaborating with UTSW, Oncologie.